TTENK/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

TTENK/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Groups
  • Trending
  • News

More

  • Pricing
  • Community
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice.TENK is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities TENK rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. TENK/calls is an independent service and is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

TTENK/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Pulling SEC filings + quote and writing the call…

TTENK/calls
The BriefMarketsAll StocksNewsScreenerCommunity
← New search
Home›Stocks›ALHC
ALHC logo

ALHC

Alignment Healthcare, Inc.

Next earnings Jul 28, 2026 (after close) · consensus $0.13 EPS, $1.34B rev

Last earnings +3.8% on 2026-04-30

Buy
$23.80
▲ +2.32%
$23.80▲ +71.84%
over 1Y
L $11.64H $23.81
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+2.3%
1W+4.8%
1M+74.5%
3M+26.9%
YTD+17.7%
1Y+71.8%
OverviewFinancialsValuationQualityTimelineFilings
Rating
Buy
Quality
B-
Valuation
Fair value
Filings
Clean
Buy
Conviction
Horizon
Long (>12mo)
12-mo target
$•••
Street · 20 analysts
Strong Buy

Fast-growing Medicare Advantage disruptor just reached breakeven with strong cash flow and only 6% share — scaling story turning real.

Revenue $3.95B · FY2025

Alignment Healthcare is a technology-enabled, clinically focused Medicare Advantage insurer for seniors, pairing its AVA data platform with an employed Care Anywhere clinical model. The growth is exceptional and the profitability inflection is the key development: FY2025 revenue grew 46.1% to $3.95B, and after years of losses (-$128M as recently as FY2024), the company reached essentially breakeven net income (-$724K) with positive operating income of $14.8M and, most importantly, operating cash flow that turned strongly positive at $140M (+302%). Membership reached 236,300 (a 30% CAGR since inception) across 45 markets and five states.

The runway is large and the quality signals are strong. Management notes Alignment holds only ~6% market share of MA enrollees in its markets (with 10-30% share in its most mature markets), and 100% of its members are in plans rated 4 stars and above — the California HMO has held 4+ stars for nine consecutive years, which drives favorable CMS rebate economics. The balance sheet carries $576M cash and modest long-term debt ($323M); the 4.94x liabilities/equity ratio largely reflects insurance medical-claims reserves rather than financial leverage.

AI-generated analysis, produced by our proprietary engine from SEC filing data.

Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 21, 2026, 4:58 PM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.

Is ALHC a buy? The one-page verdict, explained →

Financials · annual, by fiscal year

Line itemFY21FY22FY23FY24FY25
Revenue$1.17B$1.43B$1.82B$2.70B$3.95B
Gross profit—————
Operating income-$178M-$129M-$128M-$102M$14.8M
Net income-$195M-$150M-$148M-$128M-$724K
Diluted EPS-$1.14-$0.83-$0.79-$0.67$0.00
Net margin-16.7%-10.4%-8.1%-4.7%-0.0%

Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.

Key statistics

Valuation

Enterprise value$4.67B
EV / EBITDA103.4
EV / Sales1.2
EV / FCF41.3
P / FCF43.5
PEG (trailing)—
Earnings yield-0.0%
FCF yield2.3%

Quality & risk

ROIC (est.)2.3%
Free cash flow$113M
Total debt$323M
Net cash$253M
Altman Z-Score6.20 safe
Piotroski F-Score5/8

Capital returns

Buyback yield—
Dividend yield (est.)—
Shareholder yield—
Shares Δ YoY+6.5%

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Disclosure timeline

SEC · 8-Ks + reports
Routine disclosure cadence — no material red flags in recent filings.
  1. 8-K Shareholder vote2026-06-09
  2. 8-K Charter / bylaws change2026-05-12
  3. 8-K Earnings results2026-04-30
  4. 10-Q Quarterly report2026-04-30
  5. DEF 14A Proxy statement2026-04-24
  6. 8-K Material agreement2026-03-04
  7. 10-K Annual report2026-02-27
  8. 8-K Earnings results2026-02-26
  9. 8-K Reg FD disclosure2026-01-12

Recent filings

all on EDGAR ↗
4Period ending 2026-07-012026-07-02open ↗4Period ending 2026-07-012026-07-01open ↗144Filing2026-07-01open ↗4Period ending 2026-06-262026-06-26open ↗144Filing2026-06-26open ↗4Period ending 2026-06-182026-06-18open ↗144Filing2026-06-18open ↗4Period ending 2026-06-152026-06-15open ↗4Period ending 2026-06-122026-06-15open ↗144Filing2026-06-12open ↗144Filing2026-06-12open ↗4Period ending 2026-06-112026-06-12open ↗

Quality score

B-
ValueGrowthProfitHealthMom.
ValueA-
GrowthA+
ProfitabilityF
Financial healthD
MomentumA+
  • ✓Revenue growing year-over-year
  • ✗Profitable (positive net income)
  • ✗Net margin above 10%
  • ✗Return on equity above 15%
  • ✗Liabilities below 2× equity
11.6452-week24.01
Revenue
$3.95B
+46.1% YoY
Net margin
-0.0%
ROE
-0.4%
P/E
—

SEC fundamentals · FY 2025

'21'22'23'24'25

■ revenue · ■ net income, by fiscal year

Revenue$3.95B+46.1%
Net income-$724K+99.4%
Operating income$14.8M+114.5%
Diluted EPS$0.00+100.0%
Cash & equivalents$576M+33.0%
Total assets$1.07B+36.3%
Total liabilities$887M+30.2%
Stockholders' equity$179M+79.5%
Op.: 0.4%L/E: 4.94x

Frequently asked

Is Alignment Healthcare, Inc. (ALHC) a buy?
ALHC currently carries a Buy rating with 3/5 conviction, derived from its latest SEC filings. Fast-growing Medicare Advantage disruptor just reached breakeven with strong cash flow and only 6% share — scaling story turning real.
What is Alignment Healthcare, Inc.'s quality score?
ALHC scores 65.6533168106809/100 (grade B-) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

Sources: SEC EDGAR (CIK 0001832466, latest 10-Q filed 2026-04-30) · EODHD · Proprietary analysis · as of 6/21/2026, 8:58:09 PM.

Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Insider activity

Form 4 · SEC

Last 90 days: 0 open-market buys · 8 sales

2026-07-01
Hochradel Shane J.
Chief Operations Officer
Award87.7K
2026-07-01
KONOWIECKI JOSEPH S
EVP, Corporate Affairs
Sell25.0K @ $24.00$600K
2026-06-26
KONOWIECKI JOSEPH S
EVP, Corporate Affairs
Sell25.0K @ $23.00$575K
2026-06-18
KONOWIECKI JOSEPH S
EVP, Corporate Affairs
Sell25.0K @ $22.00$550K
2026-06-15
Maroney Dawn Christine
President
Sell30.0K @ $19.55$586K
2026-06-12
Kim Hyong
Chief Medical Officer
Sell36.0K @ $19.86$714K
2026-06-11
KONOWIECKI JOSEPH S
EVP, Corporate Affairs
Sell25.0K @ $21.00$525K
2026-06-10
KAO JOHN E
Chief Executive Officer
Sell74.9K @ $19.65$1.47M
2026-06-10
KAO JOHN E
Chief Executive Officer
Sell223K @ $20.60$4.59M

Earnings history

beat/miss · move
2026-04-30Beat +575.7% est▲ +3.78%8-K ↗
2026-02-26Beat +67.9% est▲ +1.44%8-K ↗
2025-10-30Beat +124.2% est▼ -5.99%8-K ↗
2025-07-30Beat +195.4% est▲ +10.36%8-K ↗
2025-05-01—▼ -5.36%8-K ↗
2025-02-27—▲ +2.36%8-K ↗

Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.

Recent news

market news →
Ensign Expands Texas Footprint With Two Skilled Nursing AcquisitionsBullish
finance.yahoo.com· 2026-07-03
1 Mooning Stock to Own for Decades and 2 That UnderwhelmBullish
finance.yahoo.com· 2026-07-03
Q1 Rundown: Molina Healthcare (NYSE:MOH) Vs Other Health Insurance Providers StocksBullish
finance.yahoo.com· 2026-07-03
Merck Stock, JPMorgan And Two Others Hit New Highs
finance.yahoo.com· 2026-07-02
Alignment Healthcare (ALHC) Is Up 10.7% After Earnings Beat, Faster Growth And Higher Star RatingsBullish
finance.yahoo.com· 2026-07-02
Healthcare Stocks Rise To The Heart Of IBD's Elite List Of Growth NamesBullish
finance.yahoo.com· 2026-07-02

Vs tracked universe

compare →

1194 tracked peers · median

TENK Score66 vs 67
Revenue growth46.1% vs 7.5%
Net margin-0.0% vs 10.0%
Return on equity-0.4% vs 12.0%
P/E— vs 26.2

News sentiment

EODHD · 31d
Bullish
+0.06
vs typical · 53 articles
↓ cooling

Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.